Does Disappointment Await Investors In These COVID-19 Treatment And Vaccine Plays?

2020-06-16 18_45_22-Syringe and Pills on Blue Background · Free Stock PhotoWhen it comes to investors piling into small-cap companies that are developing potential treatments or vaccines for COVID-19 – and causing shares of those companies to take off – Europe is no different than the U.S., with some small-cap biotech names in Europe having seen four-fold gains. Today’s article looks at a number of those companies – and whether investors are likely to end up disappointed. For more, CLICK HERE.